Predicting relapse in estrogen receptor (ER) positive breast cancer (luminal) subgroups treated with adjuvant tamoxifen.

被引：0
|
作者：
Loi, SM
Desmedt, C
Haibe-Kains, B
Lallemand, F
Gillett, C
Tutt, A
Ryder, K
Ellis, P
Harris, P
Smeds, J
Bergh, J
Cardoso, F
Piccart, MJ
Sotiriou, C
机构：
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
[2] Guys Hosp, London SE1 9RT, England
[3] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England
[4] Karolinska Hosp & Inst, CCK Canc Ctr Karolinska, Stockholm, Sweden
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S129 / S130
页数：2
相关论文
共 50 条
  • [1] Risk of early relapse in post-menopausal women with early stage, estrogen receptor positive (ER+) breast cancer on tamoxifen.
    McArthur, HK
    Olivotto, I
    Gelmon, KA
    Speers, CH
    Chia, S
    Ellard, S
    Kennecke, HF
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S124 - S124
  • [2] Molecular Signaling Distinguishes Early ER Positive Breast Cancer Recurrences Despite Adjuvant Tamoxifen.
    Liu, M. C.
    Dixon, J. M.
    Xuan, J. J.
    Riggins, R. B.
    Chen, L.
    Wang, C.
    Cho, Y.
    Zhu, Y.
    Jin, L.
    Zwart, A.
    Wang, M.
    Klimach, U. M.
    Wang, Y. J.
    Renshaw, L.
    Larionov, A.
    Miller, W. R.
    Clarke, R.
    CANCER RESEARCH, 2011, 71
  • [3] Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone
    Ingle, James N.
    Suman, Vera J.
    Solanki, Malvika H.
    Passow, Marie R.
    Campbell, Jordan D.
    Wang, Liewei
    Goetz, Matthew P.
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [4] Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
    Sherene Loi
    Benjamin Haibe-Kains
    Christine Desmedt
    Pratyaksha Wirapati
    Françoise Lallemand
    Andrew M Tutt
    Cheryl Gillet
    Paul Ellis
    Kenneth Ryder
    James F Reid
    Maria G Daidone
    Marco A Pierotti
    Els MJJ Berns
    Maurice PHM Jansen
    John A Foekens
    Mauro Delorenzi
    Gianluca Bontempi
    Martine J Piccart
    Christos Sotiriou
    BMC Genomics, 9
  • [5] Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
    Loi, Sherene
    Haibe-Kains, Benjamin
    Desmedt, Christine
    Wirapati, Pratyaksha
    Lallemand, Francoise
    Tutt, Andrew M.
    Gillet, Cheryl
    Ellis, Paul
    Ryder, Kenneth
    Reid, James F.
    Daidone, Maria G.
    Pierotti, Marco A.
    Berns, Els Mjj
    Jansen, Maurice P. H. M.
    Foekens, John A.
    Delorenzi, Mauro
    Bontempi, Gianluca
    Piccart, Martine J.
    Sotiriou, Christos
    BMC GENOMICS, 2008, 9 (1)
  • [6] Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
    Kennecke, Hagen
    McArthur, Heather
    Olivotto, Ivo A.
    Speers, Caroline
    Bajdik, Chris
    Chia, Stephen K.
    Ellard, Susan
    Norris, Brian
    Hayes, Malcolm
    Barnett, Jeff
    Gelmon, Karen A.
    CANCER, 2008, 112 (07) : 1437 - 1444
  • [7] Cognitive function in breast cancer patients treated with tamoxifen.
    Paganini-Hill, A
    Clark, L
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 455 - 455
  • [8] Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients
    Gasparini, G
    Fox, SB
    Verderio, P
    Bonoldi, E
    Bevilacqua, P
    Boracchi, P
    Dante, S
    Marubini, E
    Harris, AL
    CLINICAL CANCER RESEARCH, 1996, 2 (07) : 1191 - 1198
  • [9] Prognostic significance of autophagy related genes in estrogen receptor positive tamoxifen treated breast cancer
    Mishra, Alok
    Pateriya, Ankit
    Mishra, Anand Kumar
    Shrivastava, Ashutosh
    BIOINFORMATION, 2020, 16 (09) : 710 - 717
  • [10] Investigating tamoxifen resistance in the luminal B estrogen receptor positive breast cancer subtype: Tailoring treatment in hormone responsive breast cancer
    Loi, S.
    Sotiriou, C.
    Haibe-Kains, B.
    Lallemand, F.
    Conus, N.
    Piccart, M. J.
    Speed, T.
    McArthur, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345